Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Goetz

Showing results (251-260 of 269) with videos related to

Pageof 27
Sort By:
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.
Annals of Neurology|September 11, 1999
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's diseaseJ H Kordower, S Palfi, E Y Chen, et al.
Archives of Neurology|August 1, 1997
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic studyI Litvan, C G Goetz, J Jankovic, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophyI Litvan, V Booth, G K Wenning, et al.
Neurology|May 16, 2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamicsK Kompoliti, C H Adler, R Raman, et al.
Neurology|July 1, 1996
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshopI Litvan, Y Agid, D Calne, et al.
Neurology|July 1, 1997
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic studyI Litvan, Y Agid, N Sastry, et al.
Archives of Neurology|July 25, 1998
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic studyI Litvan, A MacIntyre, C G Goetz, et al.
Neurology|December 7, 2007
FMR1 CGG repeat length predicts motor dysfunction in premutation carriersM A Leehey, E Berry-Kravis, C G Goetz, et al.
Archives of Neurology|July 25, 1998
Clinical presentation and pharmacological therapy in corticobasal degenerationK Kompoliti, C G Goetz, B F Boeve, et al.
Pageof 27

Showing results (251-260 of 269) with videos related to

Sort By:
Pageof 27
Archives of Neurology|February 15, 2001
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson diseaseO Rascol, J G Nutt, O Blin, et al.
Annals of Neurology|September 11, 1999
Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's diseaseJ H Kordower, S Palfi, E Y Chen, et al.
Archives of Neurology|August 1, 1997
What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic studyI Litvan, C G Goetz, J Jankovic, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|July 11, 1998
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophyI Litvan, V Booth, G K Wenning, et al.
Neurology|May 16, 2002
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamicsK Kompoliti, C H Adler, R Raman, et al.
Neurology|July 1, 1996
Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshopI Litvan, Y Agid, D Calne, et al.
Neurology|July 1, 1997
What are the obstacles for an accurate clinical diagnosis of Pick's disease? A clinicopathologic studyI Litvan, Y Agid, N Sastry, et al.
Archives of Neurology|July 25, 1998
Accuracy of the clinical diagnoses of Lewy body disease, Parkinson disease, and dementia with Lewy bodies: a clinicopathologic studyI Litvan, A MacIntyre, C G Goetz, et al.
Neurology|December 7, 2007
FMR1 CGG repeat length predicts motor dysfunction in premutation carriersM A Leehey, E Berry-Kravis, C G Goetz, et al.
Archives of Neurology|July 25, 1998
Clinical presentation and pharmacological therapy in corticobasal degenerationK Kompoliti, C G Goetz, B F Boeve, et al.
Pageof 27